Globe Life (GL) Aperçu de l'action
Globe Life Inc. propose, par l'intermédiaire de ses filiales, divers produits d'assurance-vie et d'assurance-maladie complémentaire aux familles à revenu moyen inférieur et moyen aux États-Unis. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 1/6 |
| Performances passées | 4/6 |
| Santé financière | 2/6 |
| Dividendes | 4/6 |
Récompenses
Analyse des risques
GL Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Globe Life Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$154.46 |
| Plus haut sur 52 semaines | US$157.92 |
| Plus bas sur 52 semaines | US$116.73 |
| Bêta | 0.50 |
| Variation sur 1 mois | 2.22% |
| Variation sur 3 mois | 7.26% |
| Variation sur 1 an | 28.50% |
| Variation sur 3 ans | 45.77% |
| Variation sur 5 ans | 48.53% |
| Évolution depuis l'introduction en bourse | 4,985.88% |
Nouvelles et mises à jour récentes
Mise à jour du récit • May 15
GL: Buybacks And Earnings Guidance Will Shape A Balanced Forward Outlook
Analysts have adjusted their price target for Globe Life to $147. This $1 change reflects updated views on slightly higher discount rates, more moderate revenue growth, a marginally stronger profit margin, and a modestly lower future P/E assumption.
Mise à jour du récit • Apr 30
GL: Earnings Guidance And Buybacks Will Support Bullish Long Term Outlook
Analysts have kept their Globe Life price target steady at $199.00. This reflects only small adjustments to assumptions around revenue growth, profit margins, and future P/E that together leave their overall valuation view broadly unchanged.Recent updates
Mise à jour du récit • May 15
GL: Buybacks And Earnings Guidance Will Shape A Balanced Forward Outlook
Analysts have adjusted their price target for Globe Life to $147. This $1 change reflects updated views on slightly higher discount rates, more moderate revenue growth, a marginally stronger profit margin, and a modestly lower future P/E assumption.Mise à jour du récit • Apr 30
GL: Earnings Guidance And Buybacks Will Support Bullish Long Term Outlook
Analysts have kept their Globe Life price target steady at $199.00. This reflects only small adjustments to assumptions around revenue growth, profit margins, and future P/E that together leave their overall valuation view broadly unchanged.Mise à jour du récit • Apr 15
GL: Updated Capital Returns And Slightly Lower P/E Assumptions Will Guide Balanced Outlook
Analysts now see Globe Life's fair value at $146.00, down from $150.00. This reflects slightly adjusted assumptions for revenue growth, profit margin and future P/E in their updated models.Mise à jour du récit • Apr 01
GL: Higher P/E Assumptions And Capital Returns Will Shape Balanced Future Outcomes
Analysts have raised their price target on Globe Life to $150, up from $145. This change reflects updated assumptions for revenue growth, profit margins and future P/E multiples in their models.
Mise à jour du récit • Mar 18
GL: Share Repurchases And Earnings Guidance Will Support Long-Term Upside
Analysts have adjusted their price target on Globe Life slightly higher to about $172 per share, reflecting updated assumptions for revenue growth, profit margin, discount rate, and future P/E. What's in the News Globe Life's board approved a quarterly dividend of $0.3300 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (Key Developments).Seeking Alpha • Mar 14
Globe Life: Undervalued Insurance For Your Portfolio
Summary Globe Life offers a compelling long-term dividend growth profile, despite its modest 0.8% yield, making it ideal for future-focused portfolios. GL’s affordable, sticky policies drive recurring revenue and organic growth, supported by a large underinsured market and expanding exclusive agent force. Trading at a 17% discount to a $171 fair value estimate, GL’s forward P/E of 9.2 is well below historical averages, positioning it for potential revaluation. With a low payout ratio and a 20-year dividend growth streak, GL targets double-digit annual dividend hikes and could deliver 11% annual total returns through 2031. Read the full article on Seeking AlphaMise à jour du récit • Mar 04
GL: Future Earnings Outlook And Buybacks Will Support Bullish View
Analysts have maintained their Globe Life price target at $199, citing updated model inputs that reflect slightly different assumptions for the discount rate, revenue growth, profit margin, and future P/E, while still arriving at the same fair value estimate. What's in the News Globe Life's board approved a quarterly dividend of $0.33 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (company announcement).Mise à jour du récit • Feb 18
GL: Buybacks And Earnings Outlook Will Support Long-Term Upside
Analysts have adjusted their price target on Globe Life to $171.40 from $168.30. This reflects updated assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations.Mise à jour du récit • Feb 04
GL: Higher Revenue Outlook And P/E Assumptions Will Shape Balanced Future Returns
Analysts have lifted their price target on Globe Life from US$111.00 to US$145.00, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E, which together support a higher valuation framework. Valuation Changes Fair Value: price target updated from US$111.00 to US$145.00, representing a sizeable upward reset in the valuation estimate.Mise à jour du récit • Jan 20
GL: Future Earnings Guidance And Buybacks Will Support Bullish View
Analysts have raised their price target on Globe Life from about $185 to $199, citing updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted common share for the year ending December 31, 2025 (company guidance).Mise à jour du récit • Jan 06
GL: Steady Outlook And Ongoing Buybacks Will Support Long-Term Upside
Analysts have kept their price target for Globe Life broadly steady around $168.30, reflecting minor adjustments to assumptions for revenue growth, profit margin and future P/E that did not materially change their overall valuation view. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted share for the year ending December 31, 2025 (Key Developments).Mise à jour du récit • Dec 21
GL: Future Earnings Visibility And Buybacks Will Drive Long-Term Upside Potential
Analysts have raised their price target on Globe Life by approximately 1 dollar to reflect slightly higher modeled fair value, modestly improved margin and growth assumptions, and a marginally higher future P E multiple. What's in the News Issued earnings guidance for 2025, projecting net operating income of $14.40 to $14.60 per diluted share, signaling steady profit expectations (company guidance) Provided 2026 outlook with net operating income per share estimated between $14.60 and $15.30, suggesting continued earnings growth beyond next year (company guidance) Repurchased 1,274,691 shares between July 1 and September 30, 2025, equal to 1.57% of shares outstanding, for $172.95 million (buyback update) Reached 98.88% completion of a long running share repurchase program, totaling 143,773,686 shares bought back for $9,831.8 million since its announcement in August 2005 (buyback update) Valuation Changes Fair Value: increased slightly from $166.70 to $168.30 per share, reflecting a modestly higher modeled intrinsic value.Mise à jour du récit • Dec 07
GL: Expanding Earnings Guidance Will Drive Long-Term Upside Potential
Analysts have modestly raised their price target on Globe Life to approximately $166.70 per share from about $166.27. They cite slightly stronger projected profit margins, a marginally lower discount rate, and a small uptick in expected revenue growth and future earnings multiples.Mise à jour du récit • Nov 23
GL: Share Buyback Momentum And Earnings Guidance Will Drive Upside
Narrative Update on Globe Life: Analyst Price Target Adjustment Analysts have slightly lowered their fair value estimate for Globe Life by $0.18 to $166.27, citing marginal changes in projected revenue growth and profit margin expectations. What's in the News Globe Life Inc.Mise à jour du récit • Nov 08
GL: Share Repurchases And Earnings Guidance Will Drive Future Upside
Analysts have raised their price target for Globe Life slightly, increasing it from $166.27 to $166.45, based on adjusted expectations for revenue growth and profitability. What's in the News Globe Life Inc.Mise à jour du récit • Oct 25
Share Repurchases And Earnings Outlook Will Support Insurance Sector Expansion
Narrative Update: Globe Life Analyst Price Target Revision Analysts have slightly raised their fair value estimate for Globe Life, increasing the target from $165.73 to $166.27 per share. This change reflects improved expectations for profit margin and a stable growth outlook.Mise à jour du récit • Oct 11
Digital Underwriting And Agent Expansion Will Shape Insurance Future
Narrative Update: Globe Life Analyst Price Target Adjustment Analysts have raised their fair value estimate for Globe Life from $161.55 to $165.73, citing modest improvements in projected revenue growth and a slightly lower discount rate as key factors supporting the upward adjustment. What's in the News Globe Life Inc.Mise à jour du récit • Sep 27
Digital Underwriting And Agent Expansion Will Shape Insurance Future
Globe Life’s valuation metrics, including Future P/E and Discount Rate, remained essentially stable, resulting in only a marginal increase in the consensus Analyst Price Target from $160.18 to $161.55. What's in the News SEC concludes its investigation of Globe Life and does not intend to recommend an enforcement action.Article d’analyse • May 24
We Ran A Stock Scan For Earnings Growth And Globe Life (NYSE:GL) Passed With Ease
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Seeking Alpha • Jan 23
Globe Life: A Stalwart That Can Balance Growth And Profitability
Summary Globe Life demonstrates steady EPS growth due to disciplined underwriting and cost efficiency. The company targets lower to middle-income families, maintaining stable annualized premiums and high underwriting margins. Globe Life's strong liquidity, high RBC ratio, and quality investment portfolio bolster its financial health. Shares are a buy with long-term price target of $180. Read the full article on Seeking AlphaSeeking Alpha • Sep 13
Globe Life: Boring, Which Is Good As A Policyholder-But Not As An Investor
Summary Globe Life's stable share price and low dividend yield make it a lackluster investment with limited growth potential and better alternatives available. The company’s business model and performance are respectable, but there are no significant catalysts for future gains. Despite a recent share buyback, Globe Life trails its peers and broader market indices in total return, making it a "pass" for investors. Read the full article on Seeking Alpha
Nouveau récit • Aug 25
Enhanced Credibility And Strategic Growth Initiatives Promise Bright Prospects
Audit Committee's findings boost Globe Life's credibility and investor confidence by clarifying financial integrity, influencing stock value positively.Seeking Alpha • Jun 24
Globe Life: A Small Bet That The Recent Controversy Will Blow Over
Summary Globe Life Inc. shares rebounded sharply after a short report by Fuzzy Panda, caused a short-lived over 50% drop in the stock. Despite the controversy, Globe Life reported strong 1Q24 financials, increased its FY24 outlook, and has seen some recent insider purchases in the shares. Allegations of fraud and misconduct did prompt the SEC to open an informal inquiry. Despite the rebound, the stock is still cheap on a P/E basis. An analysis around Globe Life follows in the paragraphs below. Read the full article on Seeking AlphaSeeking Alpha • Apr 15
Globe Life: Betting On A Bounce To $80
Summary Globe Life experienced a significant drop in stock price after a report from Fuzzy Panda Research accused the company of unethical practices. The report compared Globe Life to other life insurance companies to build its negative narrative but did not assess industry standards or behaviors. In particular, Primerica. Fuzzy Panda held a $64.35 price target. GL has dropped below that mark. GL now has valuation metrics well below the industry average and significantly below PRI, it's most direct comparable as a life insurance company with an MLM sales structure. I believe that the stock price will bounce back to $80 or higher due to short sellers covering their positions and bullish investor speculation. Read the full article on Seeking AlphaRendement pour les actionnaires
| GL | US Insurance | US Marché | |
|---|---|---|---|
| 7D | 1.0% | 3.5% | -0.3% |
| 1Y | 28.5% | -7.1% | 26.7% |
Rendement vs Industrie: GL a dépassé le secteur US Insurance qui a rapporté -7.1 % au cours de l'année écoulée.
Rendement vs marché: GL a dépassé le marché US qui a rapporté 26.7 % au cours de l'année écoulée.
Volatilité des prix
| GL volatility | |
|---|---|
| GL Average Weekly Movement | 2.8% |
| Insurance Industry Average Movement | 4.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: GL n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de GL ( 3% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1900 | 3,695 | Frank Svoboda | home.globelifeinsurance.com |
Globe Life Inc. propose, par l'intermédiaire de ses filiales, divers produits d'assurance vie et d'assurance maladie complémentaire aux familles à revenu moyen inférieur et moyen aux États-Unis. Elle exerce ses activités dans trois secteurs : L'assurance vie, l'assurance maladie complémentaire et les investissements. La société propose des produits d'assurance vie entière, temporaire et autres, ainsi que des assurances vie pour les enfants ; des produits d'assurance complémentaire Medicare et des produits d'assurance santé complémentaire à prestations limitées, tels que des produits d'assurance accident, cancer, maladies graves, cœur, soins intensifs et autres produits de santé ; et des produits d'assurance frais de fin de vie, décès accidentel, protection hypothécaire et assurance hospitalisation.
Globe Life Inc. Résumé des fondamentaux
| GL statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$11.64b |
| Bénéfices(TTM) | US$1.18b |
| Recettes(TTM) | US$6.07b |
10.2x
Ratio P/E2.0x
Ratio P/SLe site GL est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| GL compte de résultat (TTM) | |
|---|---|
| Recettes | US$6.07b |
| Coût des recettes | US$4.02b |
| Marge brute | US$2.05b |
| Autres dépenses | US$871.51m |
| Les revenus | US$1.18b |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 15.16 |
| Marge brute | 33.73% |
| Marge bénéficiaire nette | 19.38% |
| Ratio dettes/capitaux propres | 53.6% |
Quelles ont été les performances à long terme de GL?
Voir les performances historiques et les comparaisonsDividendes
0.9%
Rendement actuel des dividendes8%
Ratio de distributionLe site GL verse-t-il des dividendes fiables ?
Voir GL l'historique des dividendes et les indices de référence| Globe Life dates des dividendes | |
|---|---|
| Date ex-dividende | Jul 06 2026 |
| Date de paiement du dividende | Jul 31 2026 |
| Jours jusqu'au dividende Ex | 46 days |
| Jours jusqu'à la date de paiement du dividende | 71 days |
Le site GL verse-t-il des dividendes fiables ?
Voir GL l'historique des dividendes et les indices de référenceAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/20 05:13 |
| Cours de l'action en fin de journée | 2026/05/20 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Globe Life Inc. est couverte par 30 analystes. 8 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Jay Gelb | Barclays |
| Jack Matten | BMO Capital Markets Equity Research |
| null null | BMO Capital Markets Equity Research |